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Cardiac arrest is a prevalent condition with a poor prognosis, attributable in part to
persistent myocardial dysfunction following resuscitation. The molecular basis of this
dysfunction remains unclear. We induced cardiac arrest in a porcine model of acute
sudden death and assessed the impact of ischemia and reperfusion on the molecular
function of isolated cardiac contractile proteins. Cardiac arrest was electrically induced,
left untreated for 12min, and followed by a resuscitation protocol. With successful
resuscitations, the heart was reperfused for 2 h (IR2) and the muscle harvested. In
failed resuscitations, tissue samples were taken following the failed efforts (IDNR). Actin
filament velocity, using myosin isolated from IR2 or IDNR cardiac tissue, was nearly
identical to myosin from the control tissue in a motility assay. However, both maximal
velocity (25% faster than control) and calcium sensitivity (pCa50 6.57 ± 0.04 IDNR vs.
6.34 ± 0.07 control) were significantly (p < 0.05) enhanced using native thin filaments
(actin+troponin+tropomyosin) from IDNR samples, suggesting that the enhanced velocity
is mediated through an alteration in muscle regulatory proteins (troponin+tropomyosin).
Mass spectrometry analysis showed that only samples from the IR2 had an increase
in total phosphorylation levels of troponin (Tn) and tropomyosin (Tm), but both IR2
and IDNR samples demonstrated a significant shift from mono-phosphorylated to
bis-phosphorylated forms of the inhibitory subunit of Tn (TnI) compared to control. This
suggests that the shift to bis-phosphorylation of TnI is associated with the enhanced
function in IDNR, but this effect may be attenuated when phosphorylation of Tm is
increased in tandem, as observed for IR2. There are likely many other molecular changes
induced following cardiac arrest, but to our knowledge, these data provide the first
evidence that this form cardiac arrest can alter the in vitro function of the cardiac
contractile proteins.
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Introduction
Sudden cardiac arrest is typically precipitated by ventricular
fibrillation or pulseless ventricular tachycardia, a life-threatening
condition characterized by an abrupt loss of blood flow resulting
in progressive global ischemia (Neumar et al., 2008). Successful
resuscitation with return of spontaneous circulation can restore
blood flow to near normal levels within minutes of an event,
however the prognosis for revived patients remains quite poor
with only ∼10% surviving to hospital discharge if it occurs
outside of a hospital (Schoenenberger et al., 1994; Eisenberg and
Mengert, 2001) and this only improves to 23% if it occurs in
a hospital setting (Roger et al., 2012). After resuscitation many
patients experience “postcardiac arrest syndrome,” characterized
by a persistent mechanical myocardial dysfunction in the absence
of large morphological changes (Kern, 2002), which is believed to
be a leading cause of the high morbidity and mortality following
cardiac arrest (Neumar et al., 2008). However, themolecular basis
of the persistent mechanical dysfunction is unclear and thus the
means to improve the extremely poor prognosis is unclear (Bolli
and Marban, 1999; Chalkias and Xanthos, 2012). For example it
is unknown whether cardiac arrest directly affects the function
of contractile proteins that give rise to the force and power
generating capacity of the heart.
At a molecular level, force and power in the heart result from
the calcium dependent sliding of actin-based thin filaments past
myosin-thick filaments in a process driven by the hydrolysis of
adenosine triphosphate (ATP). The earliest biochemical changes
that occur in the myocytes during an ischemic event are the
accumulation of metabolites including: hydrogen ions (H+),
inorganic phosphate (Pi), and adenosine diphosphate (ADP)
(Allen and Orchard, 1987; Schaefer et al., 1990; Elliott et al., 1992;
Bolli and Marban, 1999). These molecules exert direct depressive
effects on the mechanical function of the contractile apparatus,
however levels of these molecules quickly (<5min) returned to
normal with return of blood flow and therefore cannot explain
the persistent decrease in cardiac function (Allen and Orchard,
1987; Schaefer et al., 1990; Elliott et al., 1992; Bolli and Marban,
1999). Thus, the more likely cause of post-arrest myocardial
dysfunction are the persistent structural modifications of the
contractile apparatus similar to those which occur in models of
localized ischemia (Rao et al., 2007). However, to our knowledge
neither structural modifications nor functional consequences
have been identified in global ischemic event such as cardiac
arrest (Chalkias and Xanthos, 2012).
Models of more localized and cardiac ischemia have
shown that myosin, actin and thin filament calcium-dependent
regulatory proteins, troponin (Tn) and tropomyosin (Tm), which
regulate actomyosin interactions can undergo post-translational
modifications including truncation (Westfall and Solaro, 1992;
Gao et al., 1997; van Eyk et al., 1998; McDonough et al.,
1999; van Eyk and Murphy, 2001; Foster et al., 2003; Day
et al., 2007) and phosphorylation (Rao et al., 2007, 2009; Han
Abbreviations: IDNR, non-successful resuscitation after 20min; HIC,
hydrophobic interaction chromatography; IR2, successful resuscitation followed
by 2 h of reperfusion; ROSC, return of spontaneous circulation; Tn, troponin; Tm,
tropomyosin; VF, ventricular fibrillation; VNTF, native thin filament velocity.
and Ogut, 2010, 2011) which impact myofilament function.
Due to the known consequences of localized ischemia on
contractile function, we explored the time-dependent effects
of global ischemia and reperfusion on myofilament structure
and function in a porcine model. Here, we determined the
impact of a 12-min bout of cardiac ischemia via arrest and
attempted myocardial resuscitation in a porcine model on
the structural and functional characteristics of cardiac myosin
and native thin filaments. We found that the global ischemia
and subsequent reperfusion had no effect on the ability of
myosin to move actin or native thin filaments in an in vitro
motility assay, regardless of the outcome of resuscitation. While
native thin filament calcium sensitivity and velocity were not
perturbed when resuscitation was successful, calcium sensitivity
and velocity of native thin filaments was significantly enhanced in
tissue from failed resuscitation. Protein analysis by quantitative
mass spectrometry demonstrated increases in phosphorylation of
both the inhibitory subunit of Tn (TnI) and α-Tm associated with
global ischemia and reperfusion, in the absence of truncation
of TnI. In conjunction with the functional analyses, these
results suggest that the increase in native thin filament calcium
sensitivity and sliding velocity could be attributed to an increase
in the phosphorylation of TnI in the absence of accompanying
changes in α-Tm. These data provide the first assessment of
the impact of global ischemia and resuscitation on the structure
and function of the heart’s molecular motor myosin and its thin
filament binding partner.
Methods
Ischemia/Reperfusion Protocol
All surgical procedures involving animals were in strict
compliance with the NIHGuide for the Care and Use of Animals.
The parent study from which the tissue samples were obtained
was IACUC-approved and conducted in a USDA certified
laboratory. Female domestic Yorkshire swine aged 3–4 months
and weighing approximately 30–35 kg prepared as previously
described (Mader et al., 2010), were used for the cardiac arrest-
resuscitation experiments. The three animals included in this
substudy were part of a larger study involving 80 animals,
45% of which attained ROSC. During the protocol the animals
were sedated with intramuscular telazol (5mg/kg), ketamine
(2.5mg/kg), and xylazine (2.5mg/kg). Isoflurane was provided
to facilitate endotracheal intubation and intravenous (IV) access.
The inhalation anesthetic was then discontinued and a surgical
plane of anesthesia was achieved using an IV propofol bolus
(2mg/kg) followed by a continuous infusion (80 mics/kg/min)
titrated to effect. The animals were ventilated with room air,
using a volume-cycled ventilator adjusted the tidal volume and
ventilatory rate to maintain eucapnea. A nasopharyngeal probe
was placed through the oral cavity into the animal’s esophagus
to measure core body temperature. Three surface electrodes
configured to correspond to a standard lead II electrocardiogram
(ECG) surface electrodes were secured to the proximal forelimbs
and thorax.
Neuromuscular paralysis was induced with pancuronium
(4mg initial bolus IV) and an arterial introducer (8.5 Fr) was
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placed into the right femoral artery and a venous introducer
(8.5 Fr) into the right femoral vein under direct visualization.
Micro–manometer tipped pressure catheters (Mikro-Tip, Millar
Instruments, Houston, TX) were placed into the ascending
aorta and right atrium. Arterial blood gas was obtained as
soon as access was established and just prior to ventricular
fibrillation (VF) induction. All central vascular access ports
were connected to a pressurized liter bag of normal saline
containing heparin. The ECG tracing, as well as the arterial and
venous pressures were monitored and recorded continuously
throughout the experiment (PowerLab M8/30, AD Instruments,
Colorado Springs, CO). Immediately before induction of VF, a 2-
mg bolus of pancuronium was given, the propofol infusion was
discontinued, and the ventilator was disconnected.
Global ischemia and the resuscitation protocol were
performed as previously described (Mader et al., 2010). Briefly,
VF was induced by a 3-s, 60-Hz, 100-mA transthoracic
alternating current. At minute 12 of untreated VF, dynamic
baseline characteristics were again recorded and resuscitation
was attempted beginning with mechanical chest compressions
using an oxygen-powered mechanical resuscitation device
(Life-Stat Mechanical CPR System, Michigan Instruments,
Grand Rapids, MI) that provides standardized closed chest
compressions in the anterior-posterior direction at a rate
of 100/min. The device was programmed to deliver chest
compressions and ventilation (Vt = 500 cc, Fi02 = 100%) in a
ratio of 30:2.
The animals were resuscitated using a standard combination
of resuscitation drugs (see Figure 1). Attempted resuscitation
terminated after the return of spontaneous circulation (ROSC)
or 20min of failure. Animals attaining ROSC were immediately
placed back on the ventilator, a low dose propofol infusion was
restarted and titrated to optimize the effect, and norepinephrine
was given intravenously to maintain a systolic blood pressure
above 80mm Hg for 2 h. At the conclusion of each experiment,
the hearts were immediately excised, diced, and put into liquid
nitrogen. The samples were kept on dry ice during transport and
stored in a−80◦C freezer.
Cardiac tissue samples were obtained from three pig hearts
under three conditions: (1) samples from a control animal that
was subjected to the surgery but that did not experience cardiac
arrest or subsequent resuscitation and reperfusion (control); (2)
from an animal subjected to 12min of global ischemia and
attempted resuscitation for 20min that included epinephrine
(0.01mg/kg), vasopressin (0.5U/kg), amiodarone (4mg/kg),
sodium bicarbonate (1.0 mEq/kg), and metoprolol (0.2mg/kg)
but spontaneous circulation failed to return (IDNR); and (3)
from an animal that underwent 12min of global ischemia
and successful resuscitation after epinephrine (0.01mg/kg),
vasopressin (0.5 U/kg), amiodarone (4mg/kg) on the third
defibrillation attempt, followed by 2 h of sustained reperfusion
(IR2).
Proteins
Cardiac myosin was isolated from porcine ventricular tissue
based on adaptation of a method previously established for
mouse cardiac myosin (Tyska et al., 2000). Briefly a 2-mL
aliquot of extraction buffer (300mM KCl, 150mM PO4, 20mM
EDTA, 5mM MgCl2, pH 6.7, 3.3mM ATP, and 5mM DTT) was
added to ∼400mg of porcine cardiac tissue and continuously
homogenized for 12min in a 2mL dounce homogenizer. The
solution was then centrifuged (5min; 10,000 g; 4◦C) and the
supernatant was centrifuged once more for 20min at 400,000 g.
The myosin containing supernatant was then precipitated by 10-
fold dilution with ddH2O for 60min and then centrifuged for
10min at 10,000 g, and 4◦C. The supernatant was disregarded
FIGURE 1 | Global ischemia protocol. Ventricular fibrillation (VF) was
induced as previously described (Mader et al., 2010) with a transthoracic
current (100mA at 60Hz) and was untreated for 12min. VF lasted for
4min before complete electrical failure was reached (green bar) at which
point circulation stopped completely (yellow bar) and finally metabolic
failure is reached at ∼10min. (pink bar). Resuscitation efforts began
12min after induction of VF, initially with manual chest compressions
(MCC) and infusion of epinephrine (drug, 0.1mg/kg). At minute 15 we
attempted to restart circulation electrically (RS1) and at 18min. If
spontaneous circulation returned (ROSC) it was maintained for 2 h and
then the animals were sacrificed and cardiac muscle samples taken from
the left ventricle (Ischemia + 2 h reperfusion). If ROSC was not restored
then after 20min cardiac muscle samples were taken from the LV
(Ischemia + failed resuscitation). Control animals were prepared identically
but did not receive the ischemia protocol (Control). ˆ Indicates when a
drug was administered.
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and the myosin pellet was gently rinsed with cold ddH2O. The
pellet was homogenized in a minimum volume of a high salt
buffer (25mM imidazole, 600mM KCl, 1mM EGTA, 4mM
MgCl2, pH 7.4) and the concentration determined with a
spectrophotometer (extinction coefficient of 0.55, Margossian
and Lowey, 1982).
An additional purification was performed on a subset of the
cardiac myosin using hydrophobic interaction chromatography
(HIC) as previously described (Malmqvist et al., 2004) with
minor modifications. Briefly, the isolated myosin was first
dialyzed overnight at 4◦C against 1.45M ammonium sulfate
(AmSO4) and then centrifuged (15min; 10,000 g) to remove any
aggregating proteins. The supernatant was loaded on to the HIC
column (5mL Toyo pearl ether–650 M, Tosoh Biosciences Inc.,
Grove City, OH) in 1.45M AmSO4. The AmSO4 was reduced
to 1.2M causing the elution of the purified myosin, following a
collection of proteins that weakly interacted with the column.
Native thin filaments (actin, Tn complex, and Tm) were
isolated using an established protocol (Lehman et al., 1995) in
which ∼200mg of tissue was exposed to thin filament extraction
buffer (25mM imidazole, 1mM EGTA, 100mM KCl, 4mM
MgCl2, 5mM ATP, 10mM DTT, pH 7.0) and homogenized for
12min on ice (0◦C). The homogenate was initially centrifuged
(10,000 g, 4◦C) for 5min followed by a second centrifugation
(40,000 g, 4◦C) of the supernatant for 20min to remove myosin
and any bulk tissue. Subsequently, the supernatant was kept and
centrifuged (200,000 g, 4◦C) again for 45min to pellet the thin
filaments which were re-suspended in 300µL of thin filament
extraction buffer before a final clarification spin (40,000 g, 4◦C)
for 5min to remove any remaining myosin. The supernatant
was kept and then a final centrifugation was performed for
45min at 200,000 g to collect the thin filaments. The resultant
pellets were brought up in an extraction buffer (7.0 pH, 25mM
imidazole, 1mM EGTA, 100mM KCl, 4mM MgCl2, 10mM
DTT) labeled tetramethylrhodamine isothiocyanate-phallodin
(TRITC-phallodin) (Sigma-Aldrich Inc., St. Louis, MI) at a
1µM. Chicken skeletal actin was also used to assess the cardiac
myosin function and it was isolated from pectoralis muscle and
fluorescently labeled with TRITC-phallodin.
In vitro Motility
The impact of the ischemia-reperfusion of contractile protein
function was assessed using the in vitro motility assay as
described (Debold et al., 2011, 2012). Briefly, isolated myosin
(in a high salt buffer: 300mM KCl, 25mM imidazole, 1mM
EGTA, 4mM MgCl2, pH 7.4, 10mM DTT) was adhered to a
nitrocellulose coated microscope coverslip as part of a flow cell at
100µg/ml. Bovine serum albumin (0.5mg/mL) was then added
to cover any areas of the surface not coated bymyosin. The native
thin filaments were then added and allowed to incubate on the
surface for 1min in the absence of ATP. Finally a motility buffer
was added to the chamber (25mM KCl, 25mM imidazole, 1mM
EGTA, 4mM MgCl2, pH 7.4, 2mM ATP, 10mM DTT, with an
amount of CaCl2 required to achieve the appropriate free [Ca
2+])
and an oxygen scavenging system (glucose oxidase, catalase, and
catalase) to slow photo-bleaching of the fluorescently labeled
actin filaments.
The flow cells were then loaded onto a Nikon Eclipse Ti
inverted microscope with a 100 X, 1.4 NA CFI Plan Apo objective
and the fluorescent actin filaments were visualized by an ICCD
camera (Stanford Photonics, Inc., Palo Alto, CA, USA). The
video was captured by an Epix-LVDS frame grabber (Epix, Inc.,
Buffalo Grove, IL, USA) coupled to the ICCD camera. Piper
Control™ 2.5 software (Stanford Photonics, Inc., Palo Alto, CA,
USA) was used to capture three to four videos from each flow-
cell at 10 frames s−1 for 30 s. The filament motions were digitized
and tracked using an automated program (Celltrak R©, Motion
Analysis Corporation, Santa Rosa, CA). Four to five motility
experiments using separate myosin and thin filament isolations
were performed for each condition. Differences in actin and
native thin filament sliding velocities among each condition were
determined using a One-Way ANOVA followed by a Tukey’s
HSD post-hoc test. To determine the calcium sensitivity of the
native thin filaments their velocities as a function of the –log of
the calcium concentration (pCa) were fitted to the Hill equation:
V = Vmax/(1+ 10
n(pCa50−pCa))
using SigmPlot R© 11.2 (Systat Software San Jose, CA). The hill
equation derived the calcium concentration required to elicit half
maximal filament velocity (pCa50) and the Hill coefficient (n) to
gain insight into the cooperative behavior of activation.
Mass Spectrometry
In preparation for mass spectrometry denaturing SDS-PAGE
was conducted with precast 12% bis-Tris polyacrylimide gels
(BioRad, Life Science Research, Hercules, CA). The identified
bands were excised from the gel, cut into small cubes, and
placed into Eppendorf tubes. Residual stain and excess water
was removed with a 50% acetonitrile solution and the gel slices
were dried in a speed vacuum device as previously described
(Previs et al., 2012). Next, one set of samples was rehydrated
with 8µL of alkaline phosphatase (Sigma–Aldrich Inc., St. Louis,
MI) in 92µL of ammonium bicarbonate and incubated for 18 h
at 30◦C, allowing the phosphatase to thoroughly impregnate the
gel and dephosphorylate the protein samples. The samples were
dried via a speed vacuum device and subsequently rehydrated
with 2µg of trypsin (Promega, Madison, WI) in 100µL of
ammonium bicarbonate and incubated for 18 h at 37◦C. After
18 h of incubation 7µL of 90% formic acid was added to
deactivate the trypsin. The resultant peptides were extracted
with 25mM ammonium bicarbonate/50% acetonitrile solution,
dried in a speed vacuum device, and reconstituted in 0.05%
heptafluorobutyric acid.
Electrospray ionization liquid chromatography tandem mass
spectrometry (LC-MS) was carried out in data dependent mass
spectrometry mode using an LTQ ion trap mass spectrometer
(Thermo Electron Corporation) coupled to a 1mm C18 column
as previously described (Weith et al., 2012). Initial SEQUEST
searches were performed to identify peptides using the IPI human
protein sequence database (v3.75) downloaded from the EMBL-
EBI website. Subsequent searches only contained the pig cardiac
TnI (A5X497) and pig α-Tm (P42639) sequences downloaded
from UniProtKB. The degrees of site-specific TnI and α-Tm
Frontiers in Physiology | www.frontiersin.org 4 July 2015 | Volume 6 | Article 199
Woodward et al. Molecular effects of cardiac arrest
phosphorylation and truncation of the C-terminus of TnI were
determined from the extracted ion currents for specific peptides
of interest in the LC chromatograms using label free-proteomic
strategies as described in the Results Section. Phosphorylation
levels were determined using each of the five reference peptides
listed for TnI and α-Tm in the Results Section in three samples
from each group, before and after treatment with alkaline
phosphatase. Statistical significance was determined from the
individual measurements from each reference peptide using a
Student’s t-test.
Results
Changes to Contractile Protein Function
The ability of cardiac myosin to move unregulated actin
filaments in the motility assay was unaffected by the ischemic
protocol, whether followed by failed resuscitation (IDNR) or by
resuscitation and 2 h of reperfusion (IR2) (Figure 2). Due to the
labile nature of cardiac myosin we considered the notion that
the ischemic protocol might lead to a reduction in the amount
of myosin purified by the HIC column protocol (Figure 3).
However, while the myosin purified with an HIC-column moved
the actin filaments faster there was no significant difference
betweenmyosin for the control vs. either ischemic condition (IR2
and IDNR) (Figure 4). Additionally the amount of released in the
early or later absorbance peaks that typically contain myosin that
poorly hydrolyze ATP (Malmqvist et al., 2004) were not larger
than for the myosin from control tissue. These findings suggest
that the present bout of global ischemia did not make the myosin
more labile. Overall these findings suggest that the function of
myosin was not affected by the ischemic protocol employed in
FIGURE 2 | Effect of ischemia/reperfusion on Vactin. Means ± SEM
for unregulated (no Tn/Tm) actin filament velocities in the in vitro motility
assay using myosin isolated from the corresponding condition. The
myosin used was isolated from tissue from control, ischemia with 2 h of
reperfusion (IR2) and ischemia without resuscitation (IDNR). Data were
analyzed using a Kruskal–Wallis ANOVA, but all comparisons were
non-significant (p > 0.05). The data represent the average actin filament
velocities from 106 to 30 s videos from Control, 19 from IR2 and 8,
from IDNR.
this study. It also suggests that neither the subsequent failed
resuscitation IDNR nor the successful resuscitation followed by
2 h of reperfusion IR2 affected actomyosin function.
The actin binding muscle regulatory proteins troponin and
Tm that decorate actin thin filaments are also thought to be
vulnerable to modification during a bout of ischemia (Gao
et al., 1997; McDonough et al., 1999), therefore we examined
the impact of these ischemic perturbations on myosin’s ability
to translocate native thin filaments (NTF) in an in vitro
motility assay. Native thin filament velocity (VNTF) and calcium
sensitivity were unaffected for samples from the IR2myocardium
vs. the control heart (Figures 5, 6 and Table 1). However, native
thin filaments from the heart which did not survive resuscitation
(IDNR) demonstrated an increase in calcium-sensitivity (pCa50
6.57 ± 0.04 vs. 6.34 ± 0.07 control, Figure 6A and Table 1)
and a 25% enhancement (p < 0.05) in sliding velocity when
fully calcium activated, i.e., pCa 4.0 (Figure 6A). In addition,
the Hill coefficient was also increased compared to control
filaments, suggesting that myosin binding to these filaments
was more cooperative than in the control filaments, but this
did not reach statistical significance due to the high variability
of this measure under this condition (Table 1). These changes
occurred despite a similar percentage of filaments moving in
each of the conditions (Figure 6), indicating that the change
in average velocity cannot be attributed to a decrease in the
number of filaments moving. In contrast, sliding velocities and
pCa50-values for native thin filament isolated from the heart
which was successfully resuscitated and reperfused (IR2) were
indistinguishable from the control native thin filaments (Figure 6
and Table 1).
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FIGURE 3 | Representative chromatograph frommyosin purification
over an HIC column. The isolated myosin from porcine myocardium was
additionally purified using hydrophobic interaction chromotography (HIC) based
on a previously described methodology (Malmqvist et al., 2004) with minor
modifications (see Methods). Chromatograph displays absorbance at 280 nm
vs. elution volume. Proteins with minimal affinity for the column elute at high
(1.45 M) AmSO4 (first broad peak). After the AmSO4 is reduced to 1.2Mmyosin
is released (large narrow peak). This process removed impurities including actin
and likely tropomyosin, selecting for myosin and its light chains (ELC, RLC) as
shown by SDS-PAGE gel (inset). In the SDS-PAGE the left lane represents the
sample before HIC purification and the right lane after HIC purification.
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The significant functional changes to native thin filament
velocity over a range of calcium concentrations for the native
thin filaments from heart of the animal which did not
survive resuscitation (IDNR) suggested underlying structural
changes to Tn and/or Tm. We therefore used quantitative mass
spectrometry to determine the nature of these changes.
Quantification of Phosphorylation
Peptides containing phosphate including: the
mono-phosphorylated 22RSSpANYR
28 (m/z = 467.20 R) and
FIGURE 4 | Purification with HIC column enhances Vactin. Further
purification of the myosin using an HIC column nearly doubled Vactin from
both Control tissue and tissue exposed to ischemia (IR2) and 2 h of
reperfusion (p < 0.001). However, there was no difference between
conditions with either the isolated myosin or the HIC purified myosin. The
data represent the average actin filament velocities from 106 to 30 s videos
from Control and 19 from IR2, as well as five videos each for HIC purified
Control and IR2 purified samples. * Indicates significance at p < 0.05.
bis-phosphorylated 21RRSpSpANYR
28 (m/z = 585.23) peptides
coming from TnI (Figure 7); and 269AISEELDHALNDMTSpI
284
(m/z= 919.89), 269AISEELDHALNDm∗TSpI
284 (m/z= 927.89),
and 269AISEELDHALNDm
<
TSpI
284 (m/z = 935.89) peptides
coming from α-Tm were identified in the data dependent
MS2 spectra and manually confirmed (Previs et al., 2008;
Weith et al., 2012). Note, Sp represents phosphoserine and
m∗ and m
<
denote methionine sulfoxide and sulfone. The
degree of phosphorylation at these sites was determined via
a mass-balance approach (Previs et al., 2008; Weith et al.,
2012) from the abundance of the non-phosphoshorylated
analogs of these phosphopeptides in each sample prior to and
after the removal of phosphate with alkaline phosphatase.
FIGURE 5 | Effect of ischemia/reperfusion on native thin filament
velocities (VNTF). Means ± SEM for unregulated (no Tn/Tm) actin filament
velocities in the in vitro motility assay using myosin isolated from the
corresponding condition. The myosin used was isolated from control,
ischemia/2 h of reperfusion (IR2) and Ischemia without resuscitation (IDNR).
Data analyzed using a non-parametric Kruskal–Wallis ANOVA and indicated
that IDNR was significantly greater than control velocity *, (p < 0.05). The data
represent the average actin filament velocities from 20 to 30 s videos from
Control, 19 from IR2 and 16 from IDNR.
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FIGURE 6 | Velocity-pCa data. (A) Native thin filament velocity (VNTF)
plotted as a function of free [Ca++] in –log units (pCa). Thin filaments from
Control tissue are plotted with filled black dots and solid line, IR2 thin filaments
with gray diamonds and solid gray line and the filaments from IDNR are plotted
with dark gray boxes and a dashed gray line. Points represent mean ± SEM
and the data were fit with the Hill equation (see Methods). * Indicates
significantly (p < 0.05) different fromWT VNTF. (B) Percentage of native thin
filaments moving as a function of free [Ca++] symbols and lines same as in
(A). (C)Motility index, defined as the product of VNTF and percent moving
plotted as a function of free [Ca++]. One animal myocardium was used for
each condition. The data represent the average actin filament velocities from
between 3 and 20 to 30 s videos at each pCa level and for each condition.
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TABLE 1 | Parameters for velocity-pCa fits to the Hill equation.
VNTF pCa50 n
Control 6.34 ± 0.07 1.89 ± 0.48
IR2 6.47 ± 0.13 1.27 ± 0.42
IDNR 6.57 ± 0.04* 3.46 ± 1.00
VNTF indicates native thin filament velocities for filaments isolated from non-ischemic
control, ischemia followed by 2 h of reperfusion (IR2) and Ischemia followed by failed
resuscitation (IDNR) Values represent mean ± SEM. * Indicates significantly (p < 0.05)
different from control tissue. The tissue was obtained from one animal for each condition.
The data represent the average actin filament velocities from 20 to 30 s videos from
control, 19 from IR2 and 16 from IDNR.
The non-phosphorylated analogs were the properly cleaved
23SSANYR28 peptide and the sum of the ion currents for the
269AISEELDHALNDMTSI284, 269AISEELDHALNDm∗TSI284,
and 269AISEELDHALNDm
<
TSI284 peptides. Whereas this mass-
balance approach is an indirect way to measure phosphorylation
levels, it provides accurate quantification of the fraction of the
protein molecules in a sample which are phosphorylated and
obviates problems with quantification arising from mis-cleavage
when the phosphate is proximal to the tryptic cleavage site
(Previs et al., 2008). For quantification, measured ion currents
corresponding to peptides of interest were extracted from
the LC chromatogram and the area under each LC peak was
normalized using reference peptides within each sample to
account for difference in the total amount of protein loaded
onto the gel (Previs et al., 2008; Weith et al., 2012). The area
under each LC peak for the TnI peptides of interest were
normalized using the YDVEAK (m/z = 362.67), KLQLK (m/z =
629.43), ETLDLR (m/z = 746.40), NITEIADLNQK (m/z =
629.83), and IFDLR(m/z = 332.19) peptides; and the area
under each LC for α-Tm peptides of interest were normalized
using the HIAEDADR (m/z = 463.72), SLEAQAEK (m/z =
438.22), IQLVEEELDR (m/z = 622.33), LVIIESDLER (m/z =
593.83), and SIDDLEDELYAQK (m/z = 769.86) peptides as
references.
The overall percent phosphorylation of both TnI at serines
23/24 and α-Tm at serine 283 was significantly enhanced
with respect to the control (Figure 8A) in samples from
successful resuscitation followed by 2 h of reperfusion (IR2).
In contrast, the overall levels of TnI or Tm phosphorylation
of samples from the failed resuscitation (IDNR) did not
significantly differ from the control samples (Figure 8A).
However, this method of quantification is not sensitive
to changes in site-specific phosphorylation when multiple
phosphorylation sites are located within a single peptide, as
was the case for TnI serine 23/24. Therefore, we determined
if there was a shift in the phosphorylation profile between
the mono- and bis-phosphorylated states by calculating the
relative abundance of the mono-phosphorylated 22RSSpANYR
28
and bis-phosphorylated 21RRSpSpANYR
28 peptides in each
sample (Figure 8B). We observed significant reductions in
the abundance of the mono-phosphorylated peptides [0.27 ±
0.10 (IR2) and 0.19 ± 0.04 (IDNR)] and corresponding
increases in the abundance of the bis-phosphorylated peptides
[4.2 ± 1.3 (IR2) and 2.8 ± 0.7 (IDNR)] with respect to the
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FIGURE 7 | LC elution profiles and data dependent MS2 spectra for
troponin I peptides. (A) Representative LC elution profiles for the
non-phosphorylated 23SSANYR28 (red), mono-phosphorylated
22RSSpANYR28 (gray), and bis-phosphorylated 21RRSpSpANYR28 (black)
peptides. Data dependent MS2 spectra for the (B)mono-phosphorylated
22RSSpANYR28 and (C) bis-phosphorylated 21RRSpSpANYR28 peptides
showing fragment ions used for peptide identification and localization of
phosphate.
controls following the bout of ischemia regardless of survival
(Figure 8B). Therefore, under both ischemic conditions we
observed in increase in the relative abundance of the bis-
phosphorylated TnI 21RRSpSpANYR
28 peptide with respect to
the control.
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FIGURE 8 | Quantification of troponin I and α-tropomyosin
phosphorylation. (A) Percent phosphorylation of troponin I serines 23 and/or
24 and tropomyosin serine 283 in native thin filaments isolated from control
hearts, and hearts following global ischemia that did not survive attempted
resuscitation (IDNR) or survived and were subject to 2 h reperfusion (IR2). (B)
Levels of mono- (serine 24) and bis-phosphorylated (serines 23 and 24)
troponin I relative to the control. Three dephosphorylated control and
experimental samples were prepared from each heart. *p < 0.01 relative to
control and ˆp < 0.01 relative to INDR. The difference between IR2 and IDNR
was p = 0.06 for tropomyosin phosphorylation.
No Truncation of Troponin I
One of the most frequently observed structural changes
associated with ischemia is the proteolytic cleavage of the C-
terminal end of TnI (Westfall and Solaro, 1992; Gao et al., 1997;
van Eyk et al., 1998; McDonough et al., 1999; van Eyk and
Murphy, 2001). We therefore used a mass spectrometry based,
mass-balance approach to determine whether the C-terminus of
TnI was truncated during ischemia. We measured the relative
abundance of the sum of the C-terminal 195NIDALSGMEGR205
(m/z = 581.78) and 195NIDALSGm∗EGR205 (m/z = 589.77)
peptides in the control and experimental samples that would
be removed by ischemia induced proteolytic cleavage. The area
under the LC peak for the C-terminal peptide was normalized
using the TnI reference peptides used for the quantification of
phosphorylation. The abundance of the C-terminal peptide did
not differ for either group [1.09± 0.19 (IR2), 1.06± 0.26 (IDNR)]
when compared to controls. This lack of difference suggests
that the C-terminus of TnI was not truncated as a result of the
ischemic bout employed in the present study.
Discussion
Effects on the In vitro Function of the Contractile
Proteins
We examined the structural and functional effects of global
cardiac ischemia and reperfusion on the sarcomeric contractile
proteins of the myocardium to gain molecular insights into the
persistent depression in cardiac function after cardiac arrest and
resuscitation. The movement of actin filaments in an in vitro
motility assays did not differ on cardiac myosin isolated from
hearts that were subject to ventricular fibrillation followed by
either successful (IR2) or unsuccessful (IDNR) resuscitation
(Figure 2). Although we did not attempt to identify structural
changes in myosin, these findings indicate that this form of
ischemia has no effect on myosin’s ability to translocate actin
and therefore suggests any modifications do not underlie the
persistent depression in contractility following cardiac arrest.
This lack of effect of global ischemia and reperfusion on
myosin function was somewhat unexpected. Prior studies using
more localized models of ischemic, including coronary artery
occlusion, showed that both myosin and the thin filament can
be modified by the accumulation of reactive oxygen species
(Zweier et al., 1989), a putative agent of protein modification
and damage from ischemia (Bolli and Marban, 1999). These
ROS mediated changes can reduce myosin’s ability to hydrolyze
ATP (Tiago et al., 2006) and its ability to translocate actin and
generate force in vitro (Rao et al., 2007), but neither effect
was observed in the present study. In comparing the models
employed the prior studies utilized more localized and longer
durationmodels of ischemia that lasted for 15min to 1 h and they
reperfused the heart for longer periods of 24–72 h. Therefore,
the absence of an effect of ischemia on myosin’s function in
the present study may be due to the different nature of the
ischemia or the shorter duration of either the ischemic bout
and/or the subsequent reperfusion. In the present study we
used shorter bouts of ischemia (12min) because longer bouts
(>15min) result in the majority of the animals failing to be
resuscitated (Kern et al., 1996), which would strongly limit
the ability to study a model that resembles the ROSC after
cardiac arrest. The timing employed in the present study also
makes the findings more applicable to typical timing experienced
during out-of-the-hospital cardiac arrest where the average
response time of an emergency medical technician unit is
∼8min from dispatch to arrival (Cobb et al., 1999). Thus, more
localized models with longer periods of ischemia and reperfusion
may be needed to observe a significant impact on myosin
function.
Modifications to the Regulatory Proteins
Another unexpected finding based on information for more
localized bouts of ischemia was the absence of degradation of
TnI. Various models of ischemia result in proteolytic cleavage of
the C-terminal end of TnI with the amount cleavage increased
by the intensity and severity of the ischemia (Gao et al., 1997;
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McDonough et al., 1999). The resultant truncation of TnI impacts
the function, disrupting the precise interaction of TnI and the
calcium binding subunit of troponin, TnC. This interaction is
crucial for activation of the filament and its disruption has been
implicated as a partial cause of contractile dysfunction following
ischemia (Gao et al., 1997; McDonough et al., 1999) by affecting
Ca2+ sensitivity and force production (Westfall and Solaro, 1992;
van Eyk et al., 1998; van Eyk and Murphy, 2001; Foster et al.,
2003; Day et al., 2007). Therefore, we expected that TnI would
be truncated in the present study, but this was not the case in
the present study based on the LC-MS data (Figure 7). Similar
to the lack of effect on myosin function described above, the
absence of any truncation of TnI may be the result of the shorter
duration of ischemia in the present study compared to previous
studies. In support of this notion, previous demonstration of this
truncation employed bouts of ischemia that ranged from 15 to
60min, with the most severe truncations occurring with 60min
bouts (Westfall and Solaro, 1992; Gao et al., 1995, 1997; van
Eyk et al., 1998). Thus, the type of ischemia elicited by inducing
ventricular fibrillation may produce quite different structural
and functional changes in the myocardium than other forms
of ischemia. This suggests that these two forms of myocardial
stunning, while both resulting from a reduction in myocardial
blood flow may elicit distinctly different effects on the contractile
proteins.
In contrast to the lack of TnI truncation, we observed
increases in the level of TnI bis-phosphorylation on serines
23 and 24 in all samples subjected to ischemia regardless
of survival (Figure 8B) but we only observed an increase
in phosphorylation of α-Tm in the samples from the pigs
that survived resuscitation and were reperfused (Figure 8A).
Interestingly, thin filament calcium sensitivity and maximal
sliding velocities (Figures 5, 6) were only significantly affected
by this modification in the native thin filaments isolated
from samples where the animal did not survive resuscitation
(IDNR). Previous investigations have shown that the effect of
ischemia on the phosphorylation level of TnI and α-Tm is
equivocal, with some authors observing consistent decreases
(Han and Ogut, 2010, 2011) while others have observed no
change or increases in phosphorylation (Rao et al., 2007).
The discrepancies in previous findings could again result from
the different models and durations of ischemia in each study.
Our findings suggest that both TnI bis-phosphorylation at
serines 23 and 24 and α-Tm phosphorylation at serine 283
may work in parallel to alter calcium sensitivity and maximal
sliding velocities. We saw increases in calcium sensitivity and
maximal sliding velocities when the level of bis-phosphorylation
of TnI was increased in the IDNR samples. However, despite
the phosphorylation levels of TnI being even greater in the
IR2 samples as compared to the controlsthis gain of function
was lost when it occurred in conjunction with an increase
in the level of α-Tm phosphorylation. This may arise if TnI
phosphorylation alters the ability of Tn to be more sensitive to
Ca++, while Tm phosphorylation affects end-to-end contacts
and cooperative recruitment of myosin molecules to the thin
filament (Rao et al., 2009). In the present study the Tm
phosphorylation may have offset the increase in Ca++-sensitivity
mediated by the relative increase in bis-phosphorylation of TnI
(Figure 8).
Conclusions
We induced cardiac arrest in a swine model followed by
resuscitation and reperfusion in order to determine if this form
of global cardiac ischemia induces changes to the structure
and/or function of the contractile proteins of the myocardium.
We found that samples from the successful resuscitation and
reperfusion (IR2) protocol did not significantly alter the ability of
myosin to bind to and move actin, nor the ability of Tn or Tm to
regulate or modulate the actomyosin interaction (Figures 5, 6).
However, in samples from failed resuscitation (IDNR) we
observed a significant increase in the maximum sliding velocity
with native thin filaments and an increased sensitivity to Ca++
(Figures 5, 6). Since no functional effects were observed using
unregulated actin filaments (Figures 2, 4), this suggests that
the enhanced VNTF and increased Ca
++-sensitivity is mediated
through the regulatory proteins, Tn, and Tm and not through
myosin or actin. To probe the potential mechanism underlying
the function changes we used mass spectrometry to identify and
quantify modifications to the regulatory proteins. Interestingly,
samples from both the IDNR and IR2 hearts showed a significant
shift from the mono-phosphorylated to bis-phosphorylated
form of TnI while the levels of Tm phosphorylation only
significantly increased in the IR2 samples (Figure 8). Previous
experiments have shown that treatment of TnI with PKA and
reconstitution into thin filaments results in an increase in
calcium sensitivity for velocity in vitro motility assay (Hunlich
et al., 2005) and the results shown here suggest this increase
in sensitivity may be negated upon phosphorylation of Tm.
Additionally, although TnI phosphorylationmay enhance sliding
velocity, the previous report showed that TnI phosphorylation
decreases calcium sensitivity for force when a load is added
to the in vitro motility assay. This finding may explain the
inconsistencies regarding the role of TnI in altering calcium
sensitivity of muscle fiber in disease (Marston and de Tombe,
2008).
While there are likely a multitude of other changes that might
contribute to the depressed contractility and poor prognosis
following ROSC after cardiac arrest, our findings suggest there
are modifications to the phosphorylation status of the thin
filament protein that affect the function of the muscle regulatory
proteins. It will be important in subsequent studies to understand
if and how additional potential changes contribute to the
persistent alterations in cardiac contractility in response to
ROSC. Limitations of the current study include both a limited
number of animals studied and the lack of both structural
and functional data concerning the effects ROSC on the thick
filament regulatory protein myosin-binding protein C (MyBP-
C). Previous studies have shown that changes inMyBP-C content
phosphorylation levels can alter calcium sensitivity and maximal
sliding velocities (Previs et al., 2012) and that MyBP-C is a target
for truncation following cardiac ischemia (Sadayappan, 2012).
Thus, this would be a potentially interesting line of inquiry to
pursue in future studies.
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